JBJ Investment Partners’s Medtronic MDT Stock Holding History

JBJ Investment Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-180	Closed	-$16K	–	136
2019 Q1	$16K	Buy	+180	New	+$16.1K	0.01%	165

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JBJ Investment Partners's MDT Position: Q2 2019 in Review

JBJ Investment Partners sold out of Medtronic (MDT) in Q2 2019, closing a stake of 180 shares — an estimated $16K sold.

JBJ Investment Partners first reported a position in MDT in Q1 2019 and held it in 1 quarter. The position peaked at $16K in Q1 2019. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

JBJ Investment Partners reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
JBJ Investment Partners sold 180 Medtronic shares in Q2 2019, an estimated $16K.
JBJ Investment Partners first reported a position in Medtronic in Q1 2019 and held it in 1 quarter.
JBJ Investment Partners's Medtronic position peaked at $16K in Q1 2019.
1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on JBJ Investment Partners's 13F filing for Q2 2019, filed 25 Jul 2019.